Option chain shows key data for HilleVax's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for HilleVax.

HilleVax (NASDAQ:HLVX) Stock, Option Chain

HilleVax

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Gold.goldbar.goldnugget.shutterstock

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

HLVX

MORF

SVMH

WETH

Gold Falls Over 1%; HilleVax Shares Plunge

Wall street sign in New York

Equities

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Upgrades

Forex

Treasuries

Tech

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

INTC

PARAA

SEDG

U.S. stocks started the week on a neutral note, with the S&amp;P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record highs last Friday.

Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What&#39;s Driving Markets Monday?

Movers

ARHS

BENF

CJET

CLDI

CLEU

DYNT

GRFS

IDYA

IONM

JEWL

KOSS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MYNZ

NEGG

NKLA

OPTT

PLSE

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RYDE

SHPW

SIRI

SLRN

UXIN

VIVK

VRPX

ZAPP

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

HilleVax Inc

Legal

Press Releases

HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVX

HilleVax Announces Reduction in Force

Earnings

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress

Frazier Life Sciences Appoints Aditya Kohli to Partner

HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

PHAT

Agenus

Alector

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

C4 Therapeutics

Coherus BioSciences

Coya Therapeutics

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Fate Therapeutics

Genelux

Immunic

Inozyme Pharma

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Invivyd

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Lexeo Therapeutics

Macrogenics

ProKidney Corp. - Class A Ordinary Shares

ProKidney

RAPT Therapeutics

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Instil Bio

Vaxart

XBiotech

HC Wainwright & Co.

Leerink Partners

Stifel

SVB Leerink

Comments

HilleVax

HilleVax (HLVX) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell